Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. Heymach JV, Harpole D, Mitsudomi T, Taube JM, et al. N Engl J Med 2023 Oct 23. doi: 10.1056/NEJMoa2304875.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heymach JV, Harpole D, Mitsudomi T, Taube JM, et al. Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer. N Engl J Med 2023 Oct 23. doi: 10.1056/NEJMoa2304875.
PMID: 37870974